| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CADPS2_0013600 | Intron-Intron | chr7:122145964-122146232 | chr7:122505910-122506178 | 269 nt | 0.4684 |
| hsa_chr7_0099500 | Intergenic-Intergenic | chr7:122147231-122147480 | chr7:122507177-122507426 | 250 nt | 0.3840 |
| hsa_chr7_0099600 | Intergenic-Intergenic | chr7:122147309-122147513 | chr7:122507255-122507459 | 205 nt | 0.3805 |
| hsa_CADPS2_0013700 | Intron-Intron | chr7:122150598-122150787 | chr7:122510544-122510733 | 190 nt | 0.4526 |
| hsa_CADPS2_0014200 | Exon-Exon | chr7:122153303-122194743 | chr7:122513249-122554689 | 146 nt | 0.3904 |
| hsa_CADPS2_0014000 | Exon-Exon | chr7:122153303-122221344 | chr7:122513249-122581290 | 319 nt | 0.4295 |
| hsa_CADPS2_0014300 | Intron-Exon-Intron | chr7:122153303-122248265 | chr7:122513249-122608211 | 67 nt | 0.3731 |
| hsa_CADPS2_0014400 | Exon-Exon | chr7:122153303-122255353 | chr7:122513249-122615299 | 119 nt | 0.4622 |
| hsa_CADPS2_0014500 | Intron-Exon-Intron | chr7:122153303-122257584 | chr7:122513249-122617530 | 133 nt | 0.3684 |
| hsa_CADPS2_0014100 | Exon-Exon | chr7:122153303-122261593 | chr7:122513249-122621539 | 497 nt | 0.4406 |
A review of studies in humans, mice, and rats indicates that the circCADPS2 demonstrates stable expression in myocardial tissue and body fluids, with specific expression patterns associated with sudden cardiac death-related diseases [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circCADPS2 as a top up-regulated circular RNA (fold change 17.62) in brain injury tissues compared to adjacent contusion tissues, with its increased expression validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].